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HIV-1 Env undergoes conformational
changes after binding to host receptor
CD4 that allow coreceptor binding,
resulting in fusion between host and viral
membranes. Wang, Barnes et al. solved
cryo-EM structures of CD4-bound Envs,
revealing the order of changes involved in
coreceptor binding-site exposure and the
structure of the rearranged V1V2 loops..
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HIV-1 Env, a trimer of gp120-gp41 heterodimers, me-
diates membrane fusion after binding host receptor
CD4. Receptor binding displaces V1V2 loops from
Env’s apex, allowing coreceptor binding and opening
Env to enable gp41-mediated fusion. We present
3.54 A˚ and 4.06 A˚ cryoelectron microscopy struc-
tures of partially open soluble native-like Env trimers
(SOSIPs) bound to CD4. One structure, a complex
with a coreceptor-mimicking antibody that binds
both CD4 and gp120, stabilizes the displaced V1V2
and reveals its structure. Comparing partially and
fully open Envs with closed Envs shows that gp41 re-
arrangements are independent of the CD4-induced
rearrangements that result in V1V2 displacement
and formation of a 4-stranded bridging sheet. These
findings suggest ordered conformational changes
before coreceptor binding: (1) gp120 opening
inducing side-chain rearrangements and a compact
gp41 central helix conformation, and (2) 4-stranded
bridging-sheet formation and V1V2 displace-
ment. These analyses illuminate potential receptor-
induced Env changes and inform design of therapeu-
tics disrupting viral entry.
INTRODUCTION
The first step in HIV-1 infection is fusion of the viral and host cell
lipid bilayers to allow the HIV-1 capsid and its genetic material to
enter the target cell (Harrison, 2015). Fusion is accomplished by
HIV-1 Envelope (Env), a trimeric glycoprotein containing three
copies of the receptor-binding gp120 subunit and three copies
of the membrane-anchored gp41 subunit (West et al., 2014).
Binding of gp120 to the host receptor CD4 induces conforma-
tional changes that expose the binding site for a coreceptor,
CCR5 or CXCR4, whose binding results in further changes culmi-
nating in insertion of the gp41 fusion peptide into the host cell
membrane and fusion of the two bilayers (Pancera et al., 2017).Cell Host & Microbe 24, 579–592, Oc
This is an open access article undCryoelectron tomography/sub-tomogram averaging of Env tri-
mers on HIV-1 virions revealed different conformational states,
including unliganded Env in a closed, pre-fusion state with inter-
actions across the gp120 trimer apex, and open CD4-bound Env
that exhibited outwardly displaced and rotated gp120 subunits
(Liu et al., 2008). The 20 A˚ resolution of these structures pre-
cluded detailed molecular interpretations, but higher resolution
X-ray and single-particle cryoelectron microscopy (cryo-EM)
structures of soluble native-like Env trimers (SOSIPs) (Sanders
et al., 2013) in the closed, pre-fusion conformation were consis-
tent with unliganded virion-bound cryoelectron tomography Env
structures, and also revealed juxtaposition of the three gp120
V1V2 loop regions at the trimer apex that shield underlying re-
gions of the coreceptor binding site on V3 (Ward and Wilson,
2017). An intermediate resolution (8.9 A˚) single-particle cryo-
EM structure of an SOSIP Env complexed with soluble CD4
(sCD4) and the coreceptor-mimicking antibody 17b (Sullivan
et al., 1998) was consistent with the electron tomography struc-
tures of CD4-bound Env on virions (Liu et al., 2008) and showed
40 A˚ displacement of the V1V2 loops to the sides of the Env
trimer to expose V3 (Wang et al., 2016a). These results were
verified and extended in a 3.7 A˚ sCD4-and 17b-bound SOSIP
structure, which also described side-chain rearrangements in
gp120 and gp41 that were visible at higher resolution, but did
not show ordered density for the rearranged V1V2 loops (Ozor-
owski et al., 2017).
We present two cryo-EM sCD4-bound SOSIP Env structures
in complex with CD4-induced (CD4i) coreceptor-mimicking anti-
bodies and with 8ANC195, a broadly neutralizing antibody
(bNAb) that recognizes the gp120-gp41 interface (Scharf et al.,
2014, 2015; Scheid et al., 2011). The first structure, a complex
of clade A/E BG505 SOSIP Env with sCD4 and Fabs from 17b
and 8ANC195, was solved to a resolution of 3.54 A˚ (BG505-
sCD4-17b-8ANC195 complex), allowing a detailed description
of partial closure of the open sCD4-bound Env state that results
from 8ANC195 binding. The second structure, solved at 4.06 A˚
resolution, is a complex of the clade B B41 SOSIP Env (Pugach
et al., 2015) with sCD4, the CD4i antibody 21c (Xiang et al.,
2002), and 8ANC195 (B41-sCD4-21c-8ANC195 complex).
Despite binding of the 8ANC195 Fab that partially closes the
open, sCD4-bound Env conformation, the structures show rear-
rangements in gp120, including displacement of V1V2, exposure
of V3, formation of the 4-stranded bridging sheet, and formationtober 10, 2018 ª 2018 The Authors. Published by Elsevier Inc. 579
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Cryo-EM Structures of sCD4-
Bound Env Trimers
(A) 3.54 A˚ density map of BG505-sCD4-17b-
8ANC195 complex.
(B) Fitted coordinates of BG505-sCD4-17b-
8ANC195 complex.
(C) 4.06 A˚ densitymap of B41-sCD4-21c-8ANC195
complex.
(D) Fitted coordinates of B41-sCD4-21c-8ANC195
complex. The CH and CL domains of the Fabs
and D2 domain of sCD4 were disordered in both
structures and not fit into density.
See also Tables S1 and S2 and Figures S1–S5.of the a0 helix. In addition, unlike the V1V2 regions in the BG505-
sCD4-17b-8ANC195 and B41-sCD4-17b structures, the dis-
placed V1V2 loops in the B41-sCD4-21c-8ANC195 structure ex-
hibited ordered density, allowing the structure of the displaced
V1V2 to be determined. Comparisons of these partially open
Env structures with fully open structures, including an open
B41 Env complexed with b12 antibody against CD4-binding
site (Ozorowski et al., 2017), showed that Env opening results
in shifting of the gp41 helices to match post-fusion gp41 struc-
tures (Chan et al., 1997; Weissenhorn et al., 1997), and that
Env opening and structural changes in gp120, such as V1V2
displacement and bridging-sheet formation, are independent
steps. These comparisons suggest that Env opening in the
absence of V1V2 displacement, a state that may exist in equilib-
rium with closed Env, triggers gp41 rearrangements as an initial
step in the conformational changes required for fusion. A sec-
ond, CD4-dependent step, involves V1V2 displacement and
formation of the gp120 bridging sheet and a0 helix. Analyses
of these results further our understanding of HIV-1 Env confor-
mational changes leading to fusion and provide templates for
designing agents to disrupt HIV-1 entry into target cells.
RESULTS
Cryo-EM Structures of Envs Complexed with sCD4,
Coreceptor-Mimicking Antibodies, and 8ANC195
EM studies confirmed that recombinant native-like soluble gp140
Env trimers (SOSIPs) (Sanders et al., 2013) can adopt the closed
and open architectures seen on virion-bound Env trimers (Harris
et al., 2011; Sanders et al., 2013; Tran et al., 2012). Thus, the
SOSIP substitutions (SOS, a disulfide bond linking gp120 to
gp41, and IP, an Ile/Promutation in gp41) do not prevent transi-
tion to the open Env state, although interpretations of sCD4-
induced changes in gp41 must be interpreted cautiously since
SOSIP Envs lack the membrane-proximal external regions, the580 Cell Host & Microbe 24, 579–592, October 10, 2018transmembrane domains, and the cyto-
plasmic tails of gp41. For our cryo-EM
structures, each sCD4-bound SOSIP Env
wascomplexedwithFabs fromaCD4i cor-
eceptor-mimicking antibody (either 17b or
21c) (Sullivanetal., 1998;Xiangetal., 2002)
and from 8ANC195, a gp120-gp41 inter-
face bNAb (Scharf et al., 2014, 2015;
Scheidet al., 2011).CD4i Fabswereadded
to stabilize the coreceptor binding site andprevent Env closure because three CD4i Fabs cannot be accom-
modatedonclosedEnv trimers due to steric clashes (Scharf et al.,
2015). 8ANC195 Fab was added to rigidify the gp120-gp41 inter-
face and induce partial closure of fully open, sCD4-bound Env
(Scharf et al., 2015; Wang et al., 2016a), allowing investigation
of the partially open Env conformation.
Env-sCD4-Fab samples were prepared by adding 8ANC195
Fab to pre-formed open Env-sCD4-CD4i Fab complexes. Sin-
gle-particle cryo-EM structures of BG505-sCD4-17b-8ANC195
and B41-sCD4-21c-8ANC195 complexes were solved to resolu-
tions of 3.54 A˚ and 4.06 A˚, respectively (Figures 1A–1D and
S1–S4; Tables S1 and S2) (Env sequence alignments and defini-
tions of secondary structural elements are shown in Figure S5).
Each trimeric Env complex included three copies each of sCD4,
CD4i Fab, and 8ANC195 Fab. The 17b and 21c Fabs exhibited
distinct orientations relative to gp120s (Figures 1B and 1D),
each consistent with crystal structures of these Fabs complexed
with sCD4-bound gp120 cores (Diskin et al., 2010; Kwong et al.,
1998). However, the BG505 andB41 Env trimers in our two struc-
tures were similar to each other (Table S3); thus, the binding of
17b versus 21c to the sCD4-bound Envs did not influence the
extent of Env opening or the overall conformation of the Env tri-
mers. As described in the 8.9 A˚ Env-sCD4-17b-8ANC195 struc-
ture (Wang et al., 2016a), the V1V2 loops were displaced from
their location at the trimer apex to the sides of the trimer in the
newpartially open BG505 andB41 Env structures; however, por-
tions of the displaced V1V2 were ordered in the B41-sCD4-21c-
8ANC195 complex structure (Figure 1D). As seen in other sCD4-
boundEnvstructures (Ozorowski et al., 2017;Wanget al., 2016a),
the rearranged V3 loops were largely disordered in the two
partially open sCD4-bound Envs (Figures 1B, 1D, and 2A).
Comparison of Different Env Trimer Conformations
To evaluate conformational changes resulting from sCD4 and
8ANC195 Fab binding, we compared the partially open Env
Figure 2. Comparison of Env Conformations
(A) Top and side views of surface representations of Env trimers in partially open, sCD4-bound open, b12-bound open, and closed conformations. PDB: 5T3X is
shown as a representative example of a closed Env structure; inter-protomer distances on closed Env structures are similar to each other despite strain-specific
sequence differences and binding of different Fab ligands (Stadtmueller et al., 2018).
(B) Structures shown in (A) with coordinates for residues 126–198 in V1V2 and 296–330 in V3 removed to facilitate seeing positions of landmark residues: CD4bs
residues 364–372 (yellow), residue 125 and 199 at the base of V1V2 (red), and residues 295 and 331 at the base of V3 (blue). Positions of CD4bs residue 368, V1V2
base residue 124, and V3 base residue 330 are shown as spheres below their respective Env structures.
(legend continued on next page)
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trimers with a 3.7 A˚ fully open B41 SOSIP in a B41-sCD4-17b
complex (PDB 5VN3) (Ozorowski et al., 2017) and closed SOSIP
Env structures (e.g., PDB: 5T3X) (Figure 2; Table S3). We also
included a 3.6 A˚ cryo-EM structure of B41 Env complexed with
the CD4-binding site bNAb b12 (PDB: 5VN8) in which the Env
trimer exhibited an open conformation with respect to rotation
and displacement of the gp120 subunits, but the V1V2 loops
were not displaced to the sides of the Env trimer (Ozorowski
et al., 2017).
We illustrated differences in gp120 positions in partially open,
open, and closed Env trimers by measuring distances between
gp120 landmarks (the CD4bs, the base of V1V2, and the base
of V3) (Table S3) and highlighting their positions on Env struc-
tures (Figure 2A). To facilitate visualization of different gp120 ori-
entations, we also highlighted the gp120 landmark residues on
Env structures in which the coordinates for V1V2 and V3 residues
were removed, demonstrating a progression of gp120 displace-
ment relative to closed Env in partially open versus open Env
structures (Figure 2B). The sCD4-bound Envs showed outward
displacements and rotations of gp120s compared with closed
Env, with the partially open sCD4-8ANC195-bound structures
exhibiting smaller displacements from the closed Env conforma-
tion relative to the open, sCD4-bound Env conformation (Fig-
ure 2B; Table S3). The b12-bound open Env trimer also showed
outward displacement of gp120s similar to the open sCD4-
bound Envs (Figures 2A and 2B), but unlike the partially open
and open sCD4-bound Envs in which the V1V2 loops were dis-
placed to the side of Env trimer, the V1V2 loops remained ‘‘on
top’’ of the displaced gp120s in b12-bound Env, where V1V2
was oriented equivalently with respect to the rest of gp120 as
seen in closed Env structures (Figure 2D). Thus, opening of the
b12-bound Env trimer involves a rigid body movement of
the gp120-V1V2 unit such that the coreceptor binding site on
the V3 loop remains largely buried, whereas the opening of
gp120 subunits in sCD4-bound Envs includes repositioning of
V1V2 to expose the V3 loop (Figure 2D). This suggests that
Env trimer opening and CD4-induced coreceptor binding site
exposure represent two distinct steps.
Factors Contributing to Different Degrees of Env Trimer
Openness
To evaluate differences in Env trimer openness, we aligned
a gp120 monomer of our partially open BG505-sCD4-17b-
8ANC195 structure with gp120 monomers from the partially
open B41-sCD4-21c-8ANC195 structure, closed Env, and the
two forms of open Envs. The gp120 subunits of partially open
and fully open sCD4-bound Envs aligned with low root-mean-
square deviation (RMSD) values in all regions except for the
N- and C-terminal strands (b4 and b26), where the RMSDs
increased to beyond 4 A˚ (Figure 3A). The b4 and b26 strands in
the partially open sCD4-bound Envs were most similar in orien-
tation to closed Envs, with closer agreement to an 8ANC195-
bound closed Env structure than a closed Env solved in the(C) Conformational changes of a0. Structures in (A) and (B) are shownwith coordin
transparent trimer surface.
(D) gp120 monomers from structures shown in (A) and (B). b2, b3, b20, b21
representations overlaid on a transparent gp120 surface.
See also Table S3 and Figure S5.
582 Cell Host & Microbe 24, 579–592, October 10, 2018absence of 8ANC195 (Figure 3A). Taken together, these results
suggest that the b4 and b26 strands serve as a pivot point about
which the rest of the gp120 subunit moves as a rigid body to
either open Env trimer upon sCD4 or b12 binding or to partially
close the sCD4-bound Env trimer conformation upon binding
to 8ANC195.
We next investigated whether gp41 moves along with the
gp120 b4 and b26 strands by aligning gp140s that were superim-
posed on their gp120-gp41 interface residues (defined as the
gp120 and gp41 residues that include atoms within 5 A˚ of each
other) (Figures 3B and S6). With the exception of interface
residues on HR1 and the fusion peptide, the gp120-gp41 inter-
faces (highlighted in green in Figures 3B and S6) were mostly un-
changed for different degrees of openness (Figure 3B). Thus,
interactions across the gp120-gp41 interface in SOSIP Envs
remain relatively unchanged during trimer opening. If this result
extends to full-length Env trimers that do not contain the stabiliz-
ing SOSIP mutations, it suggests rigid body displacement of
gp120 b4, b26, and the core portion of gp41 except for HR1C.
gp41 Rearrangements
Each gp41 protomer in Env trimer comprises an N-terminal
fusion peptide sequence, followed by two helical regions, HR1
and HR2 (Figure S5). The fusion peptides in the partially open
SOSIP Env structures reside in a pocket at the gp120-gp41 inter-
face as seen in the fully open Env conformation (Figure S7A).
Although the ordered residues of the fusion peptide in closed
and fully open Env structures form loops, the BG505-sCD4-
17b-8ANC195 and B41-sCD4-21c-8ANC195 partially open
Env structures include ordered fusion peptide residues in an
a-helical conformation (Figures S4E, S4F, and S7A). The finding
of helical fusion peptide residues likely represents the beginning
of the formation of an energetically stable fusion peptide confor-
mation that inserts into the target cell membrane during the
fusion process (Harrison, 2015).
HR1C, the C-terminal portion of HR1, forms a parallel 3-helix
bundle in Env trimers. The HR1C helical bundle in partially
open Env gp41 subunits is extended at its N termini by ordered
residues at the C termini of HR1N (N-terminal portion of HR1)
to form longer and continuous a helices (Figure S7A). Extended
HR1C helices are observed in fully open SOSIP Env structures,
including the b12-bound open Env, but not in closed Envs (Fig-
ure S7A). In addition, the HR1C helical bundle is more compact
in both partially open and fully open Envs than the 3-helical bun-
dles in pre-fusion, closed Env structures (Figure S7A). Since the
compact HR1C conformation was also observed in the B41-b12
structure (Ozorowski et al., 2017) (Figure S7A), these changes do
not require V1V2 displacement. Notably, the compact HR1C
conformation observed in all forms of open SOSIP Env matches
the HR1C conformation seen in post-fusion gp41 structures in
which HR1N forms a continuous a helix with HR1C (Chan
et al., 1997; Weissenhorn et al., 1997) (Figures S7A and S7B).
Taken together, these observations suggest that the change toates for residues 64–73 in a0 and 98–117 in a1 in cartoon depiction overlaid on a
, V1V2 residues 126–198, and V3 residues 296–330 are shown in cartoon
Figure 3. Conformations of the gp140 Protomer
(A) Superimpositions of gp120 monomer from the BG505-sCD4-17b-8ANC195 Env trimer structure with gp120s from other Env trimer structures. Left: gp120
monomer from the BG505-sCD4-17b-8ANC195 structure with highlighted structural elements of interest. Right: gp120 from the BG505-sCD4-17b-8ANC195
structure (blue-red colors indicating RMSDs) superimposed with the indicated gp120s (gray).
(B) Superimpositions of gp140 protomer from the BG505-sCD4-17b-8ANC195 Env trimer structure with gp140s from other Env trimer structures. Left: gp140
protomers from the BG505-sCD4-17b-8ANC195 structure with highlighted structural elements of interest (first structure) and highlighted gp120-gp41 interface
regions (second structure). Right: gp140 from the BG505-sCD4-17b-8ANC195 structure (blue-red colors indicating RMSDs) superimposed with the indicated
gp120s (gray).
See also Figures S5–S7.a compact HR1C bundle that is extended at its N terminus with
HR1N helical residues represents one of the first intermediate
conformations in open structures on the path to the fusion-active
conformation (Figure S7C). As these changes are also observed
in the partially open Env trimers, 8ANC195 binding and partial
closure of the open Env conformation does not reverse HR1C
and HR1N changes induced by trimer opening.
Internal gp120 Rearrangements
gp120 folding topologies are divided into two categories based
on formation of the bridging sheet, an anti-parallel b sheet
involving gp120 b strands b2, b3, b20, and b21 (Figure 4). The
bridging sheet was first observed in structures of gp120 cores
(gp120 monomers with truncations in V1V2, V3, and the N and
C termini) in the presence and absence of sCD4 (Kwon et al.,
2012; Kwong et al., 1998) (Figure 4A). However, the sheet is
not fully formed in closed, pre-fusion Env trimers; instead of a
4-stranded anti-parallel b sheet, the b3, b20, and b21 strands
form a mixed parallel and anti-parallel 3-stranded sheet, and
the b2 residues adopt an a-helical conformation (Ward and
Wilson, 2017) (Figure 4B).
The 4-stranded bridging sheet is found in both partially open
sCD4-bound Env structures, with the rearranged V1V2 region
located between b2 and b3 strands, similar to the fully open
Env in the B41-sCD4-17b structure (Ozorowski et al., 2017). Bycontrast, the open Env in the B41-b12 complex adopts the
3-stranded b-sheet conformation of closed Env trimers (Fig-
ure 4B). Thus, the formation of the 4-stranded bridging sheet
correlates with, and is likely required for, V1V2 displacement
and exposure of the coreceptor binding site on V3. Also, in com-
monwith the open form of B41 bound to sCD4 and 17b (Ozorow-
ski et al., 2017), the partially open BG505 and B41 Envs include
the gp120 a0 helix, which interacts with the HR1 in the gp41 of an
adjacent protomer, whereas the a0 region of the gp120s in the
b12-bound open B41 Env and in closed Envs formed irregular
loops (Figure 2C).
The B41-sCD4-17b structure revealed a series of gp120 side-
chain rearrangements relative to closed Env structures; these
side-chain rearrangements were not seen in the open B41-b12
complex (Ozorowski et al., 2017) (Figures 4A, 4B, and S4A), sug-
gesting they are related to 4-stranded bridging-sheet formation
induced by sCD4 binding rather than Env opening. A subset of
the gp120 side-chain rearrangements (Tyr435gp120, Trp427gp120,
Trp112gp120, Leu111gp120, and Trp69gp120) were observed in the
17b-bound partially open structure andmonomeric gp120 struc-
tures (Figures 4A and S4A), demonstrating that (1) gp120 side-
chain rearrangements occur both in BG505 and in B41 Envs
upon binding to sCD4, (2) 8ANC195 binding and partial Env
closure does not reverse these rearrangements, and (3) the rear-
rangements are related to 4-stranded bridging-sheet formation.Cell Host & Microbe 24, 579–592, October 10, 2018 583
Figure 4. Network of Conserved Residues Regulating gp120 Conformational Changes
(A) Bridging-sheet and conserved side-chain conformations in open Env trimer and gp120 monomer structures. Left: topology diagram of 4-stranded bridging
sheet. Right: cartoon representations of b20, b21, b2, b3, a1, V1V2, and V3 overlaid on a transparent gp120 monomer surface (top) and stick representations of
side chains of conserved residues of corresponding structures (bottom).
(B) Bridging-sheet and conserved side-chain conformations in b12-bound open Env and closed Env trimer structures. Left: topology diagram of 3-stranded
bridging sheet. Right: cartoon representations of b20, b21, b2, b3, a1, V1V2, and V3 overlaid on a transparent gp120 monomer surface (top) and stick
representations of side chains of conserved residues of corresponding structures (bottom).
See also Figure S4.The fact that the side-chain positions found in sCD4-bound Env
trimers are also found in monomeric gp120 core structures,
whether or not they are complexed with sCD4, indicates that
this collection of side-chain conformations is related to formation
of the 4-stranded bridging sheet (Figure 4A).
Structure of Displaced V1V2
The V1V2 region comprises a twisted 5-strand b sheet (strands
A–D and a V2 strand) with mostly disordered connecting loops
in monomeric epitope scaffolds (Gorman et al., 2016; McLellan
et al., 2011; Pan et al., 2015; Pancera et al., 2013), closed Envs
(Ward andWilson, 2017), and the b12-bound open Env (Ozorow-
ski et al., 2017) (Figure 5A). V1V2s interact across the trimer apex
in closed Envs to shield the underlying coreceptor binding sites
on the V3 regions (Ward and Wilson, 2017) (Figure 2A) and are
displaced by 40 A˚ to the sides of Env upon sCD4 binding584 Cell Host & Microbe 24, 579–592, October 10, 2018(Wang et al., 2016a). Density observed at low contour levels for
the displaced V1V2 regions in our 8.9 A˚ cryo-EM structure of
BG505-sCD4-17b-8ANC195 was uninterpretable (Wang et al.,
2016a), and the displaced V1V2 regions were disordered in our
3.54 A˚ structure of this complex and in the 3.7 A˚ B41-sCD4-
17b structure (Ozorowski et al., 2017) (Figures 5A and 5B). How-
ever, we found interpretable density for portions of the displaced
V1V2 in the B41-sCD4-21c-8ANC195 structure (Figure 5B), likely
because 21c, unlike 17b, interacts with V1V2 (Diskin et al., 2010)
(Figure 6) to stabilize a conformation that conserves V1V2 struc-
tural elements (Figure 5A).
The density for the displaced V1V2 in the B41-sCD4-21c-
8ANC195 structure, although at lower resolution than central
parts of the complex (Figure S3D), showed interactions with
sCD4 (Figure 5C) and could be modeled as five b-strands using




Figure 5. V1V2 Conformations in Different Structures
(A) Sequence alignments of the V1V2 region from representative Env structures, including different conformations of Env trimers and monomeric V1V2 scaffolds.
The A–D and V2 strands are indicated. Disordered regions in each structure are indicated by a gray background. Potential N-linked glycosylation sites (PNGSs)
are highlighted in green and contacts with sCD4 (defined as residues in V1V2 with an atom within 5 A˚ of an sCD4 residue) in the B41-sCD4-21c-8ANC195
structure are underlined in red.
(B) Models of displaced V1V2 residues (stick representation) with accompanying density contoured at 8s (0.047 e/A˚3) for the indicated structures. Insets: cartoon
representations of the V1V2 models.
(C) Close up of V1V2 interactions with sCD4 (yellow) in the B41-sCD4-21c-8ANC195 structure. A potential interaction with V1V2 residue Arg192gp120 and sCD4 is
denoted as a black dashed line, and was identified based on distance.
(D) Cartoon representations of V1V2 regions in the indicated structures. Disordered regions are indicated by dashed lines.
(E) Topology diagrams of V1V2 structures shown in (D).closed Env trimers (Figure 5D). Our model for the displaced V1V2
density preserves the strand B-strand C and strand A–D interac-
tions observed in the V1V2 regions in closed Env and V1V2 scaf-
fold structures (Figure 5D) and predicted in molecular dynamicssimulations of the displaced V1V2 structure (Yokoyama et al.,
2016). In our model, strands A and D continue the anti-parallel
b sheet that starts and ends with the gp120 b2 and b3 strands




(legend on next page)
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and 5E). Strand A continues into strand B through a loop that
varies in length across Env strains and is disordered in most
V1V2 scaffolds and closed Env trimer structures (Figure 5A).
The loop connecting strands B and C, highly conserved across
HIV-1 strains (Los Alamos HIV Sequence Database; www.hiv.
lanl.gov/) interacts with CDRL2 and CDRH3 of 21c (Figures
6A–6C). Strand C is connected through a loop to the V2 strand,
which is then joined to the N-terminal portion of strand D through
a disordered loop. Whereas the V2 and D strands are anti-paral-
lel in V1V2 scaffold and closed Env structures, V2 appears to be
parallel to strand D in the displaced V1V2 (Figures 5D and 5E)
based on density for the strand C to V2 connection. In addition,
the short length of the strand C to V2 connection (two residues)
would not permit placement of the V2 strand in an anti-parallel
orientation relative to strand D. The change to create a parallel
V2 strand-D strand interaction could result from the rearrange-
ment of the b2 and b3 regions that occurs in the switch from
the 3-stranded bridging-sheet conformation in closed Env to
the 4-stranded bridging sheet in sCD4-bound Envs (Figure 5E).
Contacts between the displaced V1V2 and sCD4 predicted
from the 8.9 A˚ structure of BG505-sCD4-17b-8ANC105 (Wang
et al., 2016a) were revealed at higher resolution in the B41-
sCD4-21c-8ANC195 structure to involve interactions between
sCD4 strands B, E, and the D–E connecting loop with the V1V2
D and V2 strands (Figures 5A and 5C).
21c Epitope on CD4 and gp120
The epitope of 21c has been structurally characterized as
including both a foreign antigen (gp120) and a self-antigen
(CD4); indeed, it is the only HIV-1 CD4i antibody described to
bind sCD4 weakly in the absence of gp120 (Diskin et al., 2010).
A structure of the clade C CAP210 gp120 monomeric core com-
plexed with 21c and sCD4 revealed gp120 and sCD4 contacts
with 21c, but potential interactions with V1V2 could not be visu-
alized because the V1V2 region was truncated in the core gp120
construct (Diskin et al., 2010). In the B41-sCD4-21c-8ANC195
structure, 21c interactions with the core region of gp120 map
exclusively to the heavy chain, and interactions with sCD4 map
primarily to the light chain (Figure 6A), conserving critical interac-
tions observed in the gp120-21c-sCD4 crystal structure despite
gp120 sequence variations. In addition, density revealed that
the 21c light chain engages directly with the loop connecting
strands B and C of the displaced V1V2 (Figures 6A and 6F),Figure 6. 21c Epitope on gp120 and sCD4
(A) Sequence of 21c VHVL with CDR residues indicated by brackets, and sCD4-c
gp120-contacting residues in gray. Contacting residues in the 21c paratope a
each other.
(B) Structure of a 21c, sCD4, gp120 protomer in the B41-sCD4-21c-8ANC195
highlighted.
(C) 21c epitope on a gp120-sCD4 complex (surface representation seen from the
indicated regions of 21c. To prevent overinterpretation of contacts at low resolutio
R7s (0.04 e/A˚3) was observed.
(D) Superimposition of VHVL domains from structures of unliganded 21c Fab
gp120DV1V2 core (PDB: 3LQA; magenta), and 21c from the B41-sCD4-21c-8AN
(E) View of CDRs in the superimposition shown in (D).
(F) Close up of 21c interaction with V1V2 and Asn197gp120 glycan.
(G) Comparison of electrostatic surface potentials (positive potential shown as bl
core-bound 21c (middle), and B41 Env trimer plus sCD4-bound 21c (right) show
accommodate negatively charged terminal sialic acids on the complex-type Asnconsistent with binding results that showed an increase in 21c
affinity for V1V2-including gp120s (Diskin et al., 2010).
To ascertain the effects of the 21c interactions with V1V2, we
compared the structures of the 21c Fab in its free, monomeric
core gp120-, and B41-bound forms by superimposing the vari-
able domains (Figures 6D and 6E). These comparisons revealed
that 21c undergoes binding-induced conformational changes
in the presence of gp120 and sCD4, with the largest change
observed in the CDRH3 loop (RMSD = 2.4 A˚ for superposition
of 16 CDRH3 Cas in free and B41-bound 21c) (Figures 6D
and 6E). Comparison of the complexed 21c Fabs revealed minor
changes in variable domain conformations (RMSD = 0.9 A˚ for
superposition of 235 21c VH-VL Cas in the gp120-sCD4-21c
and B41-sCD4-21c-8ANC195 structures), associated with the
presence of the displaced V1V2 and a complex-type N-glycan
attached to Asn197gp120 in the B41 Env trimer (Cao et al.,
2017) that was not present in the gp120 core used for the
gp120-sCD4-21c structure (Figure 6F).
Interestingly, CDRH3 conformational changes observed in
complexed 21c structures not only allow for 21c residues
Leu105HC and Glu55HC to insert into pockets on gp120 (Diskin
et al., 2010) (Figure 6F) but also promote the formation of a
groove comprising CDRH3, CDRL2, and FRL2, which is likely
to accommodate the Asn197gp120 glycan that is observed
in >98% of HIV-1 strains (Figure 6G) (Los Alamos HIV Sequence
Database; https://www.hiv.lanl.gov/). Furthermore, binding-
induced conformational changes resulting in a more electropos-
itive groove in bound 21c compared with the free antibody
suggests interactions with negatively charged sialic acids on
the complex-type glycan attached to Asn197gp120 (Behrens
et al., 2016; Cao et al., 2017; Gristick et al., 2016).
DISCUSSION
The HIV-1 Env glycoprotein must adopt multiple conformations
to function in fusion of the viral and host cell membranes (Ward
and Wilson, 2017). Although we cannot define mechanisms for
structural transitions from static structures that, by necessity,
contain bound ligands and antibodies, by comparing our cryo-
EM structures of sCD4-bound partially open SOSIP Env trimers
with structures of Env in other conformational states, we
reveal information about how Env trimers rearrange to expose
the coreceptor binding site and describe which parts of theontacting residues highlighted in yellow, V1V2-contacting residues in red, and
nd epitope were defined as two residues containing an atom within 5 A˚ of
structure, with inset showing residues contacting V1V2, sCD4, and gp120
top). Highlighted regions of the sCD4 and gp120 surfaces are contacted by the
n, the displaced V1V2 wasmodeled as polyalanine unless side-chain density at
(PDB: 3LMJ; green), 21c Fab bound to a sCD4 complex with monomeric
C195 complex (this study; blue).
ue, negative potential shown as red) of unliganded 21c (left), sCD4 plus gp120
ing the opening of a positively charged cleft (black arrow and box) that could
197gp120 glycan on V1V2 (right panel; black sticks).
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rearrangement are reversible upon binding to a gp120-gp41
interface bNAb (Video S1). In particular, we captured an ordered
conformation of the displaced V1V2 loops that move from the
trimer apex to the sides of open Env upon sCD4 binding. We
also showed that the structural rearrangements of extending
and compacting the gp41 central helices are an initial step to
achieving an open Env conformation (Figure 7) in the SOSIP
Env trimers being compared.
With respect to the coreceptor binding site, the most relevant
feature of the closed Env trimer structure is the location of the
V1V2 loops at the trimer apex that shield the coreceptor binding
site on V3 (Figure 7A, panel 1). The apex location of the V1V2
loops and their burial of V3 requires the 3-stranded form of the
gp120 bridging sheet. The HR1C region of the three central
gp41 helices are relatively separated from each other in the
closed conformation, and the a0 region adjacent to HR1C
adopts a loop conformation (Figure 7A1).
We hypothesize that a later, but still early, conformation on the
pathway toward coreceptor binding site exposure is represented
by the b12-bound open conformation of the B41 HIV-1 Env (Fig-
ure 7A2) (Ozorowski et al., 2017). In this structure, the gp120
subunits have rotated outward from the trimer axis. However,
although the Env trimer is open, the V1V2 loops are not displaced
from their location at the top of each gp120 subunit, thus leaving
the V3 loop partially buried by V1V2 (Figure 7A2). It is unclear if
the b12 antibody captures a pre-existing open Env state that is
in equilibrium with closed Env; if so, this state is not detectable
in double electron-electron resonance spectroscopy analyses
of SOSIP Env conformations (Stadtmueller et al., 2018). Thus,
the b12-bound open state could either be induced by b12 bind-
ing or exist at levels that are spectroscopically undetectable but
that can nevertheless can be captured by b12. This state may
represent an early intermediate after sCD4 binding to the closed,
pre-fusion state, in which gp120 rotation is a prerequisite to V1V2
displacement (Figure 7A3).
The B41-b12 structure demonstrates that Env trimer can open
even without forming the 4-stranded gp120 bridging sheet,
likely based on gp41 rearrangements and rotation about the
pivot point defined by the gp120 b4 and b26 strands. Moreover,
gp120 opening in the absence of 4-stranded bridging-sheet for-
mation triggers some of the structural rearrangements seen in
sCD4-bound structures; for example, some conserved gp120
side chains (Trp69gp120, His72gp120, Leu111gp120) are rearranged
with respect to the closed structure (Figures 7A1 and 7A2). Inter-
estingly, the HR1C helices adopt the compact conformation
found in post-fusion gp41 structures (Chan et al., 1997;Weissen-
horn et al., 1997) and also include HR1N residues as part of a
longer central gp41 helical region.
The final conformation of open Env on the pathway to core-
ceptor binding is observed in the sCD4-bound Env structures
in which the gp120 subunits have opened, as in the b12-bound
conformation, but the V1V2 loops have also been displaced to
the sides of Env trimer to expose the V3 loop for interactionsFigure 7. Model for Order of Conformational Changes Leading to Core
(A) Overview of features in different HIV-1 Env trimer conformational states. Five co
are listed with their corresponding structural features. (1) PDB: 5T3Z; (2) PDB: 5V
(B) Table summarizing structural features of the conformational states listed in (A
See also Video S1.with coreceptor (Figure 7A3). However, the V3 residues are
largely disordered in this structure and in the partially open Env
structures with displaced V1V2 loops, suggesting that flexibility
in V3 facilitates interactions with coreceptor. In coreceptor bind-
ing-site-exposed open conformations, the gp120 bridging sheet
adopts a 4-stranded conformation in which the b2 residues form
a b-strand connected to the N-terminal strand A of V1V2. The b2
and b3 gp120 elements also swap positions so that the four
strands of the bridging sheet are now anti-parallel, allowing the
displacement of V1V2 from the top of each gp120 to its side,
thereby exposing V3. The HR1C helices in gp41 retain their
compact configuration with extended helical regions from
HR1N residues at their N termini. Some conserved gp120 resi-
dues adopt altered side-chain conformations that were pro-
posed to allosterically transfer the signal from the sCD4 binding
site to the gp120-gp41 interface, such that the structure of gp41
is altered (Ozorowski et al., 2017). For example, the gp120 a0
residues are now in a helical conformation that tops the HR1C
from a neighboring gp41protomer.
The open, coreceptor binding-site-exposed conformation
goes on to bind CCR5 or CCR4, adopting uncharacterized
fusion-active conformation(s) that promotes fusion of the
viral and host cell membranes. The only available structures
of a conformational state that follows the open, coreceptor
binding-site-exposed conformation are structures of 6-helical
bundles of HR1 and HR2 portions of gp41 (Chan et al.,
1997; Weissenhorn et al., 1997) (Figure 7A5), which presum-
ably represent post-fusion conformations of gp41. These
structures contain the continuous HR1N-HR1C helix in a
compact 3-helix bundle, which is similar to open, but not
closed, Env trimer structures.
Having categorized features of available Env structures in
terms of their relationship to each other and to the post-fusion
gp41 conformation, our structures address the pliability of the
sCD4-bound conformation by showing that the sCD4-bound
open conformation can partially close through binding to
8ANC195 (Video S1), a gp120-gp41 interface bNAb that also
binds closed Envs (Scharf et al., 2015). In our two Env-sCD4-
8ANC195 structures, the gp120 subunits are not as separated
from each other as in fully open conformations, therefore we
refer to this conformation as partially open (Figure 7A4). The
complexes for these structure determinations were formed by
incubating fully open, sCD4-bound Env trimers with 8ANC195,
suggesting that 8ANC195 either captured a partially open,
sCD4-bound conformation or its binding triggered partial closure
of the open conformational state. Whether the partially open
sCD4-bound conformation of Env trimer represents a dead-
end conformation of Env or a coreceptor binding site-exposed
conformation of Env that could proceed along the pathway to
viral/host cell membrane fusion is unknown. In any case,
the structural comparisons show that partial closure of the
sCD4-bound open state does not reverse the formation of
4-strand bridging sheet, V1V2 displacement, coreceptor bindingceptor Binding and Fusion
nformations that have been characterized by X-ray crystallography or cryo-EM
N8; (3) PDB: 5VN3; (4) this study; (5) PDB: 1AIK.
). coBS, coreceptor binding site; FP, fusion peptide.
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site exposure, a0 helix conformation, or the formation of
compact gp41 HR1C helices with HR1N extensions (Figure 7A4;
Video S1). However, not all of the gp120 side-chain rearrange-
ments are conserved with the fully open sCD4-bound structure.
Interestingly, an ordered portion of the gp41 fusion peptide,
which adopts a loop conformation in closed and other open
Env structures, is a-helical in both partially open Env structures.
As the fusion peptide is thought to insert into the target mem-
brane as a helix (Harrison, 2015), the partially open structures
show a propensity of the fusion peptide to shift from a loop
into a helix in preparation for mediating fusion of the viral and
host membranes.
Although disordered in other sCD4-bound complexes, the
conformation of the displaced V1V2 region was revealed in the
B41-sCD4-21c-8ANC195 complex. The secondary structural el-
ements of V1V2 and regions of flexibility indicated by disorder
are mostly maintained whether V1V2 is displaced to the sides
of Env trimer, interacts about the apex of a closed Env trimer,
or is expressed as a monomeric V1V2 scaffold. This suggests
that, in the CD4-bound conformation, the V1V2 secondary struc-
tural elements move as a rigid body about the loops extending
from strands A and D. Thus, the B41-sCD4-21c-8ANC195
structure likely reveals its architecture because of the stabilizing
effects of 21c via interactions with the B-C loop region,
while in the 17b-bound open structures, the displaced V1V2
occupies multiple positions that are averaged out during map
reconstruction.
Comparisons of available Env structures provide clues as to
what controls displacement of V1V2 to expose the coreceptor
binding site in sCD4-bound structures. We note that in all
Env structures with a 4-stranded bridging sheet, including
Env trimers in fully and partially open conformations, as well
as gp120 monomer structures plus and minus bound sCD4,
the side-chain conformations of conserved gp120 residues
Tyr435gp120, Trp427gp120, Trp112gp120, Leu111gp120, and
Trp69gp120 are consistent. By contrast, in all structures with
3-stranded bridging sheets (closed Env trimers and b12-bound
open Env), the conserved residues adopt distinct conformations.
These results suggest that the side-chain rearrangements in
these residues control the reorganization of the b2, b3, b20,
and b21 structural elements and thus regulate 4-stranded
bridging-sheet formation and coreceptor binding-site exposure.
Thus, structures of monomeric gp120 cores, which include a
4-stranded bridging sheet, mimic the sCD4-bound and corecep-
tor binding-site-exposed conformation of gp120 in Env trimers,
rather than the conformation in closed, pre-fusion Env trimers.
Many structural questions related to Env conformations
remain to be elucidated, most notably the fusion-active confor-
mation that results from coreceptor binding. However, the struc-
tures reported here provide critical information for understanding
steps leading up to coreceptor binding-site exposure, including
(1) suggesting an order for Env conformational changes, (2)
describing elements of conformational plasticity in the sCD4-
bound Env state, and (3) revealing a structure for the V1V2
regions displaced by sCD4 binding. This information addsmech-
anistic details to Env-mediated membrane fusion and provides a
more complete sCD4-bound structure that serves as a template
for understanding non-neutralizing, and potentially neutralizing,
antibody responses to open Env conformations.590 Cell Host & Microbe 24, 579–592, October 10, 2018STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
tris(2-carboxyethyl)phosphine (TCEP) Pierce Cat#20491
bis(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-il)-disulfide Enzo Cat# ALX-430-102-M010
Papain Pierce Cat#20341
HEPES Thermo Fisher Scientific Cat#15630080
MEM Non-Essential Amino Acid Solution (MEM NEAA) Thermo Fisher Scientific Cat#11140050
GlutaMAX Supplement Thermo Fisher Scientific Cat#35050061
Sodium Pyruvate Thermo Fisher Scientific Cat#11360070
Hygromycin B Thermo Fisher Scientific Cat#10687010
BG505 SOSIP.664 v3.2 (Sanders et al., 2013) N/A
B41 SOSIP.664 v 4.2 (Pugach et al., 2015) N/A
17b Fab (Thali et al., 1993) N/A
2G12 IgG (Buchacher et al., 1994) N/A
21c IgG (West et al., 2010; Xiang et al., 2002) N/A
sCD4 (Brighty et al., 1991) N/A
b12 Fab (Burton et al., 1991) N/A
8ANC195 Fab (Scharf et al., 2014) N/A
Critical Commercial Assays
FreeStyle 293 Expression Medium Thermo Fisher Scientific Cat#12338018
ProCHO-5 serum-free medium Sartorius Cat#BE12-766Q
Deposited Data
BG505-sCD4-17b-8ANC195 cryo-EM map EMDB EMDB: 7516
BG505-sCD4-17b-8ANC195 coordinates PDB PDB: 6CM3
B41-sCD4-21c-8ANC195 cryo-EM map EMDB EMDB: 9038
B41-sCD4-21c-8ANC195 coordinates PDB PDB: 6EDU
Experimental Models: Cell Lines
HEK293-6E National Research Council of Canada Cat#11565
CHO Flp-In cells Invitrogen Cat# R75807
Recombinant DNA
pTT5 mammalian expression vector (used to express all
BG505 SOSIP variants and all ligands)
National Research Council of Canada N/A
Software and Algorithms
Pymol Schro¨dinger LLC; https://www.
schrodinger.com/pymol
RRID: SCR_000305
UCSF Chimera (Pettersen et al., 2004) RRID: SCR_004097
Phenix (Adams et al., 2010) RRID: SCR_014224
Coot (Emsley and Cowtan, 2004) RRID: SCR_014222
Relion (Scheres, 2012) RRID: SCR_016274
SerialEM (Mastronarde, 2005) http://bio3d.colorado.edu/SerialEM/
Rosetta (Wang et al., 2016b) RRID: SCR_015701
Other
HiLoad 16/600 Superdex 200 pg column GE Healthcare Cat#28989335
HiTrap Q HP, 5 mL column GE Healthcare Cat#17115401
Superose 6 10/300 GL column GE Healthcare Cat#17517201
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REAGENT or RESOURCE SOURCE IDENTIFIER
2G12 5 ml column made in-house using using
NHS-activated HP resin and 2G12 IgG
GE Healthcare Cat#17071601
Protein A column GE Healthcare Cat#17040301
400 Mesh Quantifoil R1.2/1.3 copper grids EM Resolutions QR1213400Cu50
300 Mesh Quantifoil R1.2/1.3 gold grids EM Resolutions QR1213400Au50CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Pamela J.
Bjorkman (bjorkman@caltech.edu). The Bjorkman laboratory cannot lawfully distribute clones in the pTT5 vector. Those wishing to
obtain these clones must first obtain a license from the National Research Council of Canada (see Key Resources Table).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cells Lines
HEK293-6E (female) and CHO Flp-In (female) cell lines were stored at liquid nitrogen temperature. Before transfection, HEK293-6E
cells were maintained in FreeStyle 293 Expression Medium, CHO Flp-In cells were maintained in ProCHO5 medium supplemented
with HEPES, GlutaMAX, MEM NEAA, Sodium Pyruvate, and Hygromycin B. Cells were maintained at 37C in a humidified shaker at
5% CO2.
METHOD DETAILS
Protein Expression and Purification
His6-tagged Fabs from 17b, and the 8ANC195G52K5 variant of 8ANC195were expressed by transient transfection in HEK293-6E cells
(National Research Council of Canada) and purified from cell supernatants using Ni-NTA chromatography and size exclusion chro-
matography (SEC) as described (Scharf et al., 2015). The heavy and light chain genes encoding 21c IgG were isolated as described
(West et al., 2010) from an Epstein Barr virus-transformed human B-cell line (Xiang et al., 2002) obtained from James Robinson
(Tulane University), and 21c IgG was expressed by transient transfection in HEK 293-6E cells. 21c IgG was isolated from transfected
cell supernatants by Protein A chromatography (GE Healthcare), and 21c Fab was obtained by digesting with immobilized papain
(Pierce) at 10 mg ml1 and purified by protein A (GE Healthcare) and SEC chromatography as described (Diskin et al., 2010).
His6-tagged sCD4 D1D2 (domains 1 and 2; residues 1–186 of mature CD4) was expressed by transient transfection in HEK293-
6E cells and purified by Ni-NTA chromatography and SEC.
BG505 SOSIP.664 v3.2 (in vector pTT5, National Research Council of Canada), a native-like soluble gp140 trimer (Sanders et al.,
2013) including the ‘SOS’ substitutions (A501Cgp120, T605Cgp41), the ‘IP’ substitution (I559Pgp41), the N-linked glycan sequence at
residue 332gp120 (T332Ngp120), an enhanced gp120-gp41 cleavage site (REKR to RRRRRR), and a stop codon after residue
664gp41 (Env numbering according to HX nomenclature) was expressed in HEK293-6E cells in the absence of kifunensine and
was purified from cell supernatants by 2G12 immunoaffinity chromatography and SEC as previously described (Wang et al.,
2017). B41 SOSIP.664 v4.2 (Pugach et al., 2015) was expressed in CHO Flp-In cells (Invitrogen) using vector pIPP4 (Chung et al.,
2014) using cell lines kindly provided by Al Cupo and John Moore (Weill Cornell Medical College) and purified as described for
BG505. All proteins were stored at 4C in 20 mM Tris, pH 8.0, and 150 mM sodium chloride (TBS buffer) supplemented with
0.02% (w/v) sodium azide.
Sample Preparation
BG505-sCD4-17b-8ANC195 and B41-sCD4-21c-8ANC195 complexes were prepared by incubating purified Env with sCD4 at a 1:3
molar ratio (gp140 protomer:sCD4) for 4 h at room temperature, followed by subsequent incubation with a 1:3molar ratio of CD4i Fab
(gp140 protomer:17b or 21c) overnight at 4C. Complexes were isolated by SEC in TBS (20 mM Tris pH 8.0, 100mM NaCl) using a
Superose 6 10/300 column (GE Healthcare) and peak fractions analyzed by SDS-PAGE. Fractions corresponding to the Env-sCD4-
CD4i complex were pooled and a 10-fold molar excess of 8ANC195 Fab was added before incubation at room temperature for 2 h.
Complexes were again isolated by SEC using a Superose 6 10/300 column (GE Healthcare), analyzed by SDS-PAGE, and pooled.
Purified BG505-sCD4-17b-8ANC195 and B41-sCD4-21c-8ANC195 complexes were diluted to 200 mg/mL and 350 mg/mL in TBS,
respectively, and vitrified in liquid ethane using a Mark IV Vitrobot (FEI). Sample grids were prepared by adding 3 mL of complex
to glow discharged 400 Mesh Quantifoil R1.2/1.3 copper grids.e2 Cell Host & Microbe 24, 579–592.e1–e4, October 10, 2018
BG505-sCD4-17b-8ANC195 Complex Cryo-EM Data Collection and Processing
Images were recorded using SerialEM (Mastronarde, 2005) on a Titan Krios electron microscope equipped with Gatan K2 Summit
direct detector. Exposures (15 s) were divided into 50 subframes with a dose rate of 3 electrons,pixel1,subframe1. After binning
by two, each image was 4k34k and 1.31 A˚ per pixel. A total of 3454 movies were collected using a 1-2.5 mm defocus range. The
micrographs were motion corrected using MotionCor2 (Zheng et al., 2017) (Figure S1A) and contrast transfer function (CTF) estima-
tions were calculated using CTFFIND4 (Rohou and Grigorieff, 2015) (Figure S1B). 2215micrographs with CTF fitting beyond 4 A˚ were
selected for automated particle picking using EMAN 2.2 (Ludtke et al., 2017). Subsequent steps were performed using RELION2
(Kimanius et al., 2016). A total of 548,229 particles were picked and sorted using initial 2D classifications. 213,791 particles from
good 2D classes were selected for another round of 2D classification, which generated 195,755 ‘‘good’’ particles (Figure S1C).
For 3D classification, an intermediate resolution cryo-EM structure of the BG505-sCD4-17b-8ANC195 complex (EMDB 8407)
(Wang et al., 2016a) was low-pass filtered to 60 A˚ to serve as the reference, and then 195,755 particles were classified into 10 different
3D classes assuming only C1 symmetry (Figure S1C). Using 143,099 particles from six 3D classes as input for 3D refinement with C3
symmetry resulted in the highest resolution (4.68 A˚) (Figure S1C). These particles were movie refined and polished before the final 3D
refinement step, during which the Fab CHCL and sCD4 D2 domains were masked out. After post-processing, the final resolution esti-
mated by the gold-standard FSC (Scheres and Chen, 2012) was 3.54 A˚ (Figures S1C and S3A).
B41-sCD4-21c-8ANC195 Complex Cryo-EM Data Collection and Processing
Images were recorded using SerialEM (Mastronarde, 2005) on a Titan Krios electron microscope equipped with Gatan K2 Summit
direct detector. Exposures (10 s) were divided into 50 subframes with a dose rate of 2 electrons,pixel1,subframe1. After binning
by two, each image was 4k34k and 1.31 A˚ per pixel. A total of 2531 movies were collected using a 1.7-3.5 mm defocus range. Sub-
sequent steps were performed in RELION2 (Kimanius et al., 2016). Themicrographsweremotion corrected usingMotionCor2 (Zheng
et al., 2017) (Figure S2A) and CTF estimations were calculated using CTFFIND4 (Rohou and Grigorieff, 2015) (Figure S2B). Single
particles were manually selected in Relion (1000 particles) and used to create an initial particle stack that was 2D classified to
generate a template for autopicking in Relion. Reference free, 2D classification of 474645 auto-picked particles was performed,
and 346264 particles corresponding to class averages of the complex were selected (Figure S2C). For 3D classification, a model
structure of the Env-sCD4-21c-8ANC195 complex was generated by replacing 17b Fab with 21c Fab in the partially-open
BG505-sCD4-17b-8ANC195 structure (PDB: 5THR) (Wang et al., 2016a). The 21c Fab binding angle was determined by aligning
gp120s from the gp120-sCD4-21c crystal structure (PDB: 3LQA) (Diskin et al., 2010) and the BG505-sCD4-17b-8ANC195 structure.
Themodeled structure was low-pass filtered to 60 A˚ to serve as the initial 3D reference, and then 346264 particles were classified into
4 different 3D classes, during which C3 symmetry was assumed and the Fab CHCL domains were masked out (Figure S2C). Using
305049 particles from three 3D classes as input for 3D refinement with C3 symmetry resulted in the highest resolution (4.39 A˚)
(Figure S2C). These particles were movie refined and polished before the final 3D refinement step. After post-processing, the
final resolution estimated by the gold-standard FSC (Scheres and Chen, 2012) was 4.06 A˚ (Figure S3A). Regions distal to the
gp120-gp41 core, including 21c, sCD4, and the displaced V1V2, were further classified and refined in Relion to enable de novomodel
building (See Figures S2C and S3 for details).
Cryo-EM Model Building
Coordinates for individual components of the 3.54 A˚ BG505-sCD4-17b-8ANC195 cryoEM structure were docked into their corre-
sponding density regions using UCSF Chimera (Pettersen et al., 2004). The following coordinate files were used for docking:
gp120 from a B41-sCD4-17b complex structure in an open conformation (PDB: 5VN3), gp41 from the same structure, sCD4 D1
domain (PDB: 2NXY), 17b Fab (PDB: 2NXY) (Zhou et al., 2007), 8ANC195 Fab (PDB: 4P9M) (Scharf et al., 2014). The docked coor-
dinates were used as the template for RosettaCM (Song et al., 2013) to build an initial model of BG505 Env, after which the model
were manually modified in Coot (Emsley and Cowtan, 2004) to remove residues that did not fit into density or clashed with other
components. Coordinates for BG505 plus sCD4 and the Fabs were refined by applying C3 symmetry using Rosetta (Tange, 2011;
Wang et al., 2016b). Coordinates for ordered N-linked glycans from PDB: 5T3X and PDB: 5VN3 Env structures (Gristick et al.,
2016; Ozorowski et al., 2017) were fit separately as rigid bodies at potential N-linked glycosylation sites (PNGSs) at which EM
density was apparent (Figure S4B), and glycan rings outside of EM density were removed. The entire complex was refined using
phenix.real_space_refine with secondary structure restraints for protein and geometric restraints for protein and N-glycan residues
(Adams et al., 2010; Afonine et al., 2018; Agirre et al., 2015; Gristick et al., 2017) (Table S1).
An initial model was generated for the 4.06 A˚ B41-sCD4-21c-8ANC195 cryoEMmap by docking coordinates of individual compo-
nents into their corresponding density regions with UCSF Chimera (Pettersen et al., 2004). Coordinates for gp120-gp41, sCD4 D1
domain, 21c Fab, and 8ANC195 Fab were obtained from PDB: 5VN3, 2NXY, 3LMJ, and 4P9M, respectively. Docked coordinates
were initially rigid-body refined in Coot (Emsley and Cowtan, 2004), followed by several cycles of refinement in Phenix (Adams
et al., 2010; Afonine et al., 2018) and manual rebuilding in Coot. Coordinates for ordered N-linked glycans from PDB: 5T3X and
PDB: 5VN3 Env structures (Gristick et al., 2016; Ozorowski et al., 2017) were fit separately as rigid bodies at potential N-linked glyco-
sylation sites (PNGSs) where EM densities for N-glycans were apparent (Figure S4B), and subsequently trimmed and refined in Coot
to fit the cryo-EM map.
Density corresponding to the previously-uncharacterized V1V2 residues 129-195 was interpreted in the B41-sCD4-21c-8ANC195
structure as follows. After focus classification and refinement on the 21c, sCD4, V1V2 region (Figures S2C and S3), we identifiedCell Host & Microbe 24, 579–592.e1–e4, October 10, 2018 e3
density characteristic of a 2-stranded anti-parallel b-sheet that resembled the strand B–connecting loop–strand C conformation in
known V1V2 structures (Figure S4G). An initial polyalaninemodel for strand B-connecting loop-strandC residues 154-174was gener-
ated using coordinates from a closed BG505 crystal structure (PDB: 5T3Z) and manually docked into density (Figure S4G). The re-
maining portions of V1V2 could be placed by first building residues to continue the b2 strand into strand A and residues preceding b3
as strand D. We next found density compatible with a b-strand that could form a b-sheet interaction with strand D and assigned that
as the V2 strand. Remaining density appearing to connect strands A and B via a long loop were left unmodeled due to uncertainty of
the sequence register. b-strand restraints were applied to strands A-D and V2 throughout refinement in both Coot and Phenix. The
entire complex was refined using phenix.real_space_refine with secondary structure restraints for protein and geometric restraints
for protein and N-glycan residues (Adams et al., 2010; Afonine et al., 2018; Agirre et al., 2015; Gristick et al., 2017) (Table S2).
DATA AND SOFTWARE AVAILABILITY
Cryo-EM reconstructions of the BG505-sCD4-17b-8ANC195 and B41-sCD4-21c-8ANC195 complexes have been deposited in
the Electron Microscopy Data Bank under the accession numbers 7516 and 9038, respectively. Coordinates for atomic models
of the BG505-sCD4-17b-8ANC195 and B41-sCD4-21c-8ANC195 complexes have been deposited in the Protein Data Bank under
the accession numbers 6CM3 and 6EDU, respectively.e4 Cell Host & Microbe 24, 579–592.e1–e4, October 10, 2018
